FEATURED ARTICLES
A Biomarker Playbook For Building Faster, Smarter Clinical Trials
Not every trial needs a biomarker, but every development leader should be assessing whether they can be effectively used to improve trial design, boost enrollment, reduce operational waste, and increase the likelihood that a study will answer the question it was built to answer.
-
Breaking Barriers In Rare Disease Clinical Trials
Priovant Therapeutics CEO Ben Zimmer shares lessons learned from rare disease VALOR trial exploring a new therapy for the treatment of dermatomyositis.
-
Justice In Human Participant Research: Reinterpreting Belmont For Contemporary Clinical Trials
Experienced IRB professional Stephanie Pyle revisits the Belmont Report to consider what its principle of “justice” means for research studies developed and conducted today.
-
Philanthropy Empowers And Accelerates Testing Of Drug Combinations In T1D
City of Hope’s Alberto Pugliese, MD, discusses how philanthropic gifts helped launch a landmark multi-center trial to test a combination therapy using repurposed drugs for the treatment of Type 1 Diabetes.